Kelly Snyder
About Kelly Snyder
Kelly Snyder is a Clinical Study Manager (CTM II) at BeiGene, specializing in Hematology/Oncology clinical trials with extensive experience in all phases of clinical development.
Current Role at BeiGene
Kelly Snyder currently serves as a Clinical Study Manager (CTM II) at BeiGene. In this role, she manages clinical trial projects through effective leadership and delegation to a cross-functional study execution team (CST). She is responsible for developing trial plans, including site monitoring, pharmacy and lab manuals, risk mitigation strategies, trial budgets, and site selection/feasibility. Her expertise in site recruitment and study start-up is a significant asset to her team.
Previous Experience at BeiGene
Before her current position, Kelly Snyder held two prior roles at BeiGene. From 2018 to 2021, she worked as an Associate Clinical Study Manager (CTM I), and from 2017 to 2018, she served as a Project Manager. These roles helped her gain in-depth experience in all phases of clinical development, from first-in-human trials through Phase 3. Her responsibilities included CRO/vendor oversight and contributing to company-wide process improvements.
Clinical Operations Experience
Kelly Snyder has a robust background in clinical operations, having worked at Medivation as a Clinical Study Assistant in the Clinical Operations department from 2016 to 2017. Additionally, she has previously worked with Meeting Protocol Worldwide as a Program Coordinator and at NCGS, Inc. as a Clinical Research Assistant. Her diverse roles within the clinical operations spectrum have equipped her with comprehensive skills in managing different facets of clinical research.
Educational Background
Kelly Snyder has pursued extensive education in her field. She completed an Extended Education Postbaccalaureate Program in Clinical Trials Design and Management (Biotechnology) at San Francisco State University. Previously, she earned her undergraduate degree from Southern Methodist University, where she studied from 2004 to 2008. Her foundational education was completed at Redwood High School, where she studied from 2000 to 2004.
Specialization and Skills
Kelly specializes in hematology/oncology clinical trials and is experienced in all phases of clinical development, from first-in-human to Phase 3 trials. Her skills encompass site recruitment, study start-up, CRO/vendor oversight, and company-wide process improvement. Additionally, she handles people management, including performance oversight, development, quarterly check-ins, and year-end performance reviews. Her expertise allows her to manage clinical trial projects effectively and ensure their successful execution.